Clinical Trial

A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia

Name: A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia — clinical trial record (NCT07233018)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated November 18, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Summary

A Clinical Study to Investigate the Safety and Efficacy of CT0991 in Patients with Relapsed/Refractory Acute Myeloid Leukemia.

Trial Details

NCT Number	NCT07233018
Lead Sponsor	MEI HENG
Conditions	Relapsed/Refractory Acute Myeloid Leukemia(AML)
Enrollment	24 participants
Start Date	2025-11-18
Primary Completion	2026-06-30 (estimated)
Study Completion	2027-05-30 (estimated)
Updated on ClinicalTrials.gov	2025-11-18